Christopher Posner, Director at Cara Therapeutics, Inc. (CARA), sold 2,000 shares at $15.82 ($32K) on 2020-11-19, disclosed to the SEC on 2020-11-23.
Open-market sale of $32k CARA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CARA | SELL | 2024-11-06 | $1K | — | Filing → |
| CARA | SELL | 2024-08-02 | $1K | — | Filing → |
| CARA | SELL | 2024-05-06 | $3K | — | Filing → |